| AEC | Aminoethyl carbazole |
| COX-2 | Cyclooxygenase 2 |
| CVD | Chronic venous disease |
| DMSO | Dimethyl sulfoxide |
| DT | Diosmetin-3-O-β-D-glucuronide |
| ELISA | Enzyme-linked immunosorbent assay |
| EVC2 | Class 2 elastic venous compression devices |
| FGF-2 | Fibroblast growth factor 2 |
| GDPR | General Data Protection Regulation |
| HIF | Hypoxia inducible factor |
| IL-12 | Interleukin 12 |
| IL-1β | Interleukin 1β |
| IL-6 | Interleukin 6 |
| IL-8 | Interleukin 8 |
| MAPK | Mitogen-activated protein kinases |
| MMP | Matrix metalloproteinase |
| NF-κB | Nuclear factor-kappa B |
| NK1 | Neurokinin-1 receptor |
| NO | Nitric oxide |
| PBS | Phosphate-buffered saline solution |
| PGE2 | Prostaglandin E2 |
| SP | Substance P |
| TNF | Tumor necrosis factor |
| VEGF-A | Vascular endothelial growth factor A |
| VEGF-C | Vascular endothelial growth factor C |